Home Blog Page 24

Blog

Pharma Marketing Blog

Random

Can an In-home Electronic Pillbox Solve Our Medication Error Problem?

Pharma Guy - June 22, 2007

Tactical Overload…Building a Linear & Cohesive Brand Plan

Brian Torres and Brian Williams - May 28, 2020

FDA Warns GSK About Enlarged Avodart Ad Imagery

Pharma Guy - February 25, 2009

Amgen Wants to Own Your Protected Health Information in Exchange for...

Pharma Guy - October 28, 2015

The Day Pharma Tchotchkes Died

Pharma Guy - October 4, 2016

Bottom Drops Out of Market: Buy! Buy!

Pharma Guy - October 9, 2008

E-Commerce Strategies: Optimizing Online Sales for Pharmaceuticals

Katriana Zommers - October 31, 2023

eDetailing Technology Spells Death of Traditional Pharma Salesman & Birth of...

Pharma Guy - May 10, 2011

Will Pharma Lobbying Ensure Lynching of Public Insurance Option?

Pharma Guy - July 6, 2009

Bean Counters Stifle Pharma Market Research

Pharma Guy - March 21, 2012

1...232425...241 Page 24 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Strategic pharmaceutical launch planning showing healthcare experts, scientific collaboration, and market preparation activities before drug approval.

The Invisible Launch: How Blockbuster Brands Build Demand Before Approval

June 16, 2026

Pharmaceutical marketing concept showing competitive gravity attracting scientific influence, stakeholder engagement, healthcare access, and market leadership.

Beyond Market Share: Why Competitive Gravity Determines Who Wins the Category

June 15, 2026

Pharmaceutical evidence supply chain showing clinical data moving from research and publications to medical guidelines, healthcare professionals, and commercial market influence.

The Evidence Supply Chain: How Clinical Data Becomes Commercial Influence

June 15, 2026